Scott Dessain MD, PhD

Dr. Scott Dessain is a highly accomplished individual with a diverse background in medicine and biochemistry. He holds a MD PhD degree from Yale University School of Medicine and a B.A. in Biochemistry from Brown University.

Dr. Dessain has held various prestigious positions in renowned organizations. He is the Founder and Chief Scientific Officer of OCMS Bio, LLC. Previously, he served as The Joseph and Roy Gordon Chair of Clinical Oncology and Research at Lankenau Institute for Medical Research. Additionally, he was the Founder and Chair of the Scientific Advisory Board at Immunome, Inc.

Dr. Dessain is a seasoned author, having co-authored the book 'Preserving the Promise: Improving the Culture of Biotech Investment' published by Elsevier Science. His academic journey includes roles as an Associate Professor at Lankenau Institute for Medical Research, Assistant Professor of Medicine at Thomas Jefferson University, and Instructor in Medicine at Massachusetts General Hospital.

Furthermore, Dr. Dessain brings a wealth of experience from his time as a Fellow in Medical Oncology at Dana-Farber Cancer Institute, Post-doctoral fellow at Whitehead Institute for Biomedical Research, and Internal Medicine Intern and Resident at Brigham and Women's Hospital. His extensive educational and professional background showcases his dedication to the field of medicine and research.